Logo
x

Search category

Subscribe Now

BioṆTech

BioNTech and DualityBio Report the Initiation of P-III Trial for BNT323/DB-1303 to Treat Metastatic Breast Cancer

BioNTech and DualityBio Report the Initiation of P-III Trial for BNT323/DB-1303 to Treat Metastatic Breast Cancer

  • January 23, 2024
Moderna's Patent Revoked by the European Patent Office (EPO) due to BioNTech Vaccine Dispute

Moderna's Patent Revoked by the European Patent Office (EPO) due to BioNTech Vaccine Dispute

  • November 22, 2023
PharmaShots Weekly Snapshots (October 09–13, 2023) _

PharmaShots Weekly Snapshots (October 09–13, 2023) _

  • October 14, 2023
BioNTech and OncoC4 Initiate Pivotal P-III Trial of Gotistobart (BNT316/ONC-392) in Patients with Metastatic Non Small Cell Lung Cancer

BioNTech and OncoC4 Initiate Pivotal P-III Trial of Gotistobart (BNT316/ONC-392) in Patients with Metastatic Non Small Cell Lung C...

  • June 30, 2023
BioNTech Signed an Exclusive License and Collaboration Agreements with DualityBio for Two ADC Therapies to Treat Solid Tumors

BioNTech Signed an Exclusive License and Collaboration Agreements with DualityBio for Two ADC Therapies to Treat Solid Tumors

  • April 3, 2023
BioNTech Signs an Exclusive Worldwide License and Collaboration Agreement with OncoC4 to Co-Develop and Commercialize ONC-392

BioNTech Signs an Exclusive Worldwide License and Collaboration Agreement with OncoC4 to Co-Develop and Commercialize ONC-392

  • March 21, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.